The best diabetes medication if you have kidney disease can vary by the severity of your kidney damage. You may need to use one that does not require dose adjustment based on your kidney function.

If required, last In-person meeting paid at £80 for the day. Looking for: People with a personal experience of bladder or kidney cancer (or other urological cancers). Cancer Research UK have ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

According to the authors, "These results support the use of Benmelstobart plus anlotinib as a new first-line treatment for advanced RCC.” ...

The signs and symptoms of kidney cancer that alert people and their healthcare providers to its presence have changed dramatically in recent years. In the past, the classic triad of flank pain, blood ...

Kidney stones are hard objects made from chemicals in your pee. They may be as tiny as a grain of salt or as big as a corn kernel. The stones can be brown or yellow, smooth or rough. They're a ...

The causes of kidney cancer are unknown. Some factors can increase the risk of developing kidney cancer. The causes of kidney cancer are unknown, But there are certain things that can affect the ...

There are four stages of passing a kidney stone: The stone forms, leaves the kidney, reaches the bladder and causes pressure, and finally, exits the body. They're common, with about 10% of people in ...

This year alone, 81,000 people will be diagnosed with kidney cancer and more than 14,000 will die from it. Renal cell carcinoma is the most common form of it, and it can be difficult to treat as ...

The Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy designation to the CAR-T cell therapy ALLO-316 for the treatment of adults with advanced or metastatic ...

“Based on these data, casdatifan has the potential to be a future treatment option for kidney cancer. I am particularly interested in planned research into novel combinations for casdatifan in ...